Pham et al. reported that sesamin reduces palmitic acid-induced lipid toxicity in human hepatocellular carcinoma cell line (HepG2) and promotes liver lipid metabolism by activating the estrogen receptor alpha/calcium/calmodulin-dependent protein kinase β/AMPK signaling pathway (12). Here, ESR1 is linked to hepatocellular carcinoma.